Predictors of mortality in patients with hereditary hemorrhagic telangiectasia

por Thompson, K. P., Nelson, J., Kim, H., Pawlikowska, L., Marchuk, D. A., Lawton, M. T., Faughnan, Marie E.
Publicado 2021

Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia

por Thompson, K. P., Sykes, J., Chandakkar, P., Marambaud, P., Vozoris, N. T., Marchuk, D. A., Faughnan, M. E.
Publicado 2022

Utility of modified Rankin Scale for brain vascular malformations in hereditary hemorrhagic telangiectasia

por Thompson, K. P., Nelson, J., Kim, H., Weinsheimer, S. M., Marchuk, D. A., Lawton, M. T., Krings, T., Faughnan, M. E.
Publicado 2021